Use of intravenous immunoglobulins as an adjunct in the conservative management of chylothorax

Paediatric Anaesthesia

Volumn 9, Issue 1, 1999, Pages 89-92

  Mohan, H ^a   Paes, M L ^a   Haynes, S ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cardiac surgery; Chylothorax; Intravenous immunoglobulin; Septicaemia

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN;

ARTICLE; CASE REPORT; CHYLOTHORAX; CONGENITAL HEART DISEASE; CONSERVATIVE TREATMENT; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPTICEMIA; THORACIC DUCT;

EID: 0032930361     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.1999.00261.x     Document Type: Article

References (25)

1. 1 Le Coultre C, Oberhansli I, Mossaz A. et al. Postoperative chylothorax in children: Differences between vascular and traumatic origin. J Pediatr Surg 1991; 26: 519-523.
2. 2 Nguyen DM, Shum-Tim D, Dobell ARC. et al. Chylothorax following pediatric cardiac surgery. J Card Surg 1995; 10: 302-308.
3. 3 Co TUI, Barcham IS, Chafiroff BGP. Ligation of the thoracic duct and post hemorrhage plasma protein levels. Surg Gynecol Obstet 1944; 51: 37-40.
4. 4 Cain JC, Grindlay JH, Bollman JL. et al. Lymph from liver and thoracic duct - an experimental study. Surg Gynecol Obstet 1947; 85: 559-62.
5. 5 Paes HL, Powell H. Chylothorax: an update. Br J Hosp Med 1994; 51: 482-490.
6. 6 Bond SJ, Guzzetta PC, Snyder ML, et al. Management of pediatric postoperative chylothorax. Ann Thorax Surg 1993; 56: 469-473.
7. 7 Bessone LN, Fergusson TB, Burford TH. Chylothorax. Ann Thorac Surg 1971; 12: 527-550.
8. 8 Randolph JC, Gross RE. Congenital chylothorax. Arch Surg 1957; 74: 405-419.
9. 9 Selle JG, Snyder WH, Schreiber JT. Chylothorax; indications for surgery. Ann Surg 1973; 177: 245-249.
10. 10 Ullibari JI, Sanz Y, Fuentes C, et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 1990; ii: 258.
11. 11 Azizkhan RG, Canfield J, Alford BA. et al. Pleuroperitoneal shunts in the management of neonatal chylothorax. J Pediatr Surg 1983; 18: 842-850.
12. 12 Murphy MC, Newman BM and Rodgers BM. Pleuroperitoneal shunts in the management of persistent chylothorax. Ann Thorac Surg 1989; 48: 195-200.
13. 13 Ferguson MK, Little AG, Skinner DB. Current concepts in the management of post operative chylothorax. Ann Thorac Surg 1981; 31: 542-545.
14. 14 Robinson CLN. The management of chylothorax. Ann Thorac Surg 1985; 39: 90-95.
15. 15 Fischer GW, Wiseman LE. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotic. Scand J Infect Dis-Suppl. 1990; 73: 17-22.
16. 16 Hill HR. Intravenous immunoglobulin use in the neonate: role in prophylaxis and therapy of infection. Pediatr Infect Dis 1993; 12: 549-558.
17. 17 Amor J, Ott E, Ibbott FA. et al. The effect of monthly gamma globulin administration on morbidity and mortality from infection in premature infants during the first year of life. Pediatr 1963; 32: 4-9.
18. 18 Fischer GW, Wilson SR, Hunter KW. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococcus. J Cl Immunol 1982; 2: 315-355.
19. 19 Christensen RD, Brown MS, Hall DC. et al. Effect of neutrophil kinetics and serum opsonic capacity of intravenous sepsis. J Pediatr 1991; 118: 606-614.
20. 20 De Souza VR, Carreno MP, Kaveri SV. et al. Selective induction of IL-1 receptor antagonist and IL-8 in human monocytes by normal polyspecific IgG. Eur J Immunol 1995; 25: 1267-1273.
21. 21 Toungouz M, Denys CH, Degroote D. et al. In vitro inhibition of TNF alpha and IL-6 production by IVIG. Br J Haematol 1995; 89: 698-703.
22. 22 Sidoropoulos D, Blochwell BU, Von Muralt G. et al. Immunoglobulin substitution bei der behandlung der neonatalen sepsis. Schweiz Med Wochenschr 1981; 111: 1649-1655.
23. 23 Freidman C, Wender DF, Temple DM. et al. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the new born. Am J Perinatol 1989; 6: 453-456.
24. 24 Haque KN, Zaidi MH, Bahakim H. IgM enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child 1988; 142: 1293-1296.
25. 25 Haque K. Intravenous immunoglobulins in neonatal sepsis. Br J Int Care 1997; 7:1: 1216.